Farzaneh Moghadam

Person

Tempe, AZ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Modulating human Cas9-specific host immune response
- Patent number 12,084,691
- Issue date Sep 10, 2024
- Arizona Board of Regents on behalf of Arizona State University
- Radwa Ewaisha
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Synthetic immunomodulation with a CRISPR super-repressor in vivo
- Patent number 11,884,925
- Issue date Jan 30, 2024
- Arizona Board of Regents on behalf of Arizona State University
- Samira Kiani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CRISPR logic circuits for safer and controllable gene therapies
- Patent number 11,773,407
- Issue date Oct 3, 2023
- Arizona Board of Regents on behalf of Arizona State University
- Samira Kiani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulating human Cas9-specific host immune response
- Patent number 11,208,640
- Issue date Dec 28, 2021
- Arizona Board of Regents on behalf of Arizona State University
- Radwa Ewaisha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Modulating Human Cas9-Specific Host Immune Response
- Publication number 20240368572
- Publication date Nov 7, 2024
- Arizona Board of Regents on behalf of Arizona State University
- Radwa Ewaisha
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SYNTHETIC IMMUNOMODULATION WITH A CRISPR SUPER-REPRESSOR IN VIVO
- Publication number 20240117364
- Publication date Apr 11, 2024
- Arizona Board of Regents on behalf of Arizona State University
- Samira KIANI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Modulating Human Cas9-Specific Host Immune Response
- Publication number 20220162574
- Publication date May 26, 2022
- Arizona Board of Regents on behalf of Arizona State University
- Samira Kiani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHETIC IMMUNOMODULATION WITH A CRISPR SUPER-REPRESSOR IN VIVO
- Publication number 20210380990
- Publication date Dec 9, 2021
- Arizona Board of Regents on behalf of Arizona State University
- Samira KIANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRISPR-Based Synthetic Gene Circuits as Next Generation Gene Therap...
- Publication number 20210154326
- Publication date May 27, 2021
- Arizona Board of Regents on behalf of Arizona State University
- Samira Kiani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CRISPR LOGIC CIRCUITS FOR SAFER AND CONTROLLABLE GENE THERAPIES
- Publication number 20210155954
- Publication date May 27, 2021
- Arizona Board of Regents on behalf of Arizona State University
- Samira Kiani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Modulating Human Cas9-Specific Host Immune Response
- Publication number 20200377871
- Publication date Dec 3, 2020
- Arizona Board of Regents on behalf of Arizona State University
- Radwa Ewaisha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Farzaneh Moghadam

Person

Patents Grantslast 30 patents

Modulating human Cas9-specific host immune response

Synthetic immunomodulation with a CRISPR super-repressor in vivo

CRISPR logic circuits for safer and controllable gene therapies

Modulating human Cas9-specific host immune response

Patents Applicationslast 30 patents

Modulating Human Cas9-Specific Host Immune Response

SYNTHETIC IMMUNOMODULATION WITH A CRISPR SUPER-REPRESSOR IN VIVO

Modulating Human Cas9-Specific Host Immune Response

SYNTHETIC IMMUNOMODULATION WITH A CRISPR SUPER-REPRESSOR IN VIVO

CRISPR-Based Synthetic Gene Circuits as Next Generation Gene Therap...

CRISPR LOGIC CIRCUITS FOR SAFER AND CONTROLLABLE GENE THERAPIES

Modulating Human Cas9-Specific Host Immune Response